Sunrise Pharmaceutical Inc
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 665 East Lincoln Avenue, Rahway, New Jersey (NJ) 07065, United States (USA)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3004813394 · DUNS 168522378
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2026-03-31
- NAIDrug Quality Assurance2023-01-27
- VAIDrug Quality Assurance2018-01-18
- NAIDrug Quality Assurance2017-04-06
- NAIDrug Quality Assurance2014-01-08
- VAIDrug Quality Assurance2011-10-04
- VAIDrug Quality Assurance2010-12-20
- OAIDrug Quality Assurance2009-07-17
Drugs this plant is listed as making
8 distinct drugs across 14 products name this site in their FDA label.
- butalbital, acetaminophen and caffeineSunrise Pharmaceutical, Inc
- Chlordiazepoxide Hydrochloride and Clidinium BromideSunrise Pharmaceutical, Inc.
- folic acidSunrise Pharmaceutical, Inc.
- methscopolamine bromideUnichem Pharmaceuticals (USA), Inc.
- phentermine hydrochlorideSunrise Pharmaceutical, Inc.
- sodium polystyrene sulfonateSunrise Pharmaceutical, Inc.
- SulfasalazineSunrise Pharmaceutical, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.